US Stock MarketDetailed Quotes

NewAmsterdam Pharma (NAMS)

Watchlist
  • 33.200
  • -0.810-2.38%
Close Apr 16 16:00 ET
  • 33.100
  • -0.100-0.30%
Pre 04:27 ET
3.82BMarket Cap-19.30P/E (TTM)

NewAmsterdam Pharma (NAMS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-23.73%636.24M
-23.73%636.24M
66.29%702.95M
71.62%739.16M
68.03%808.48M
145.03%834.19M
145.03%834.19M
--422.73M
3.35%430.71M
--481.15M
-Cash and cash equivalents
-36.51%490M
-36.51%490M
27.36%538.41M
30.92%563.86M
55.55%748.42M
126.68%771.74M
126.68%771.74M
--422.73M
3.35%430.71M
--481.15M
-Short-term investments
134.18%146.24M
134.18%146.24M
--164.54M
--175.3M
--60.06M
--62.45M
--62.45M
----
----
----
Receivables
8.67%23.15M
8.67%23.15M
293.49%20.25M
265.33%19.75M
-60.97%1.61M
1,032.64%21.31M
1,032.64%21.31M
--5.15M
-13.77%5.41M
--4.13M
-Taxes receivable
-28.04%231K
-28.04%231K
-94.11%206K
-89.43%346K
15.54%171K
-68.09%321K
-68.09%321K
--3.5M
--3.27M
--148K
-Other receivables
9.23%22.92M
9.23%22.92M
1,117.68%20.04M
809.28%19.4M
-63.81%1.44M
2,298.17%20.98M
2,298.17%20.98M
--1.65M
-65.96%2.13M
--3.99M
Prepaid assets
89.26%14.99M
89.26%14.99M
-21.74%7.83M
18.40%10.94M
183.79%7.21M
77.53%7.92M
77.53%7.92M
--10M
--9.24M
--2.54M
Restricted cash
--1.32M
--1.32M
--1.31M
----
----
--0
--0
----
----
----
Total current assets
-21.74%675.7M
-21.74%675.7M
67.25%732.33M
72.86%769.85M
67.54%817.3M
148.97%863.41M
148.97%863.41M
--437.87M
5.28%445.35M
--487.82M
Non current assets
Net PPE
-15.60%568K
-15.60%568K
-21.41%569K
-21.32%620K
336.69%607K
566.34%673K
566.34%673K
--724K
547.41%788K
--139K
-Gross PPE
-15.60%568K
-15.60%568K
-21.41%569K
-21.32%620K
336.69%607K
566.34%673K
566.34%673K
--724K
--788K
--139K
Goodwill and other intangible assets
-23.78%407K
-23.78%407K
-25.97%439K
-13.28%470K
3.29%502K
214.12%534K
214.12%534K
--593K
-99.39%542K
--486K
Investments and advances
--92.61M
--92.61M
--53.09M
--44.17M
----
--0
--0
----
----
----
Non current prepaid assets
----
----
----
----
----
--0
--0
--0
-92.08%8K
--16K
Total non current assets
7,653.44%93.58M
7,653.44%93.58M
4,007.74%54.1M
3,282.81%45.26M
73.01%1.11M
294.44%1.21M
294.44%1.21M
--1.32M
-98.50%1.34M
--641K
Total assets
-11.03%769.28M
-11.03%769.28M
79.06%786.43M
82.48%815.11M
67.55%818.41M
149.10%864.62M
149.10%864.62M
--439.19M
-12.75%446.69M
--488.46M
Liabilities
Current liabilities
Payables
89.08%8.97M
89.08%8.97M
-48.40%3.63M
11.75%5.9M
-28.69%6.09M
-71.97%4.74M
-71.97%4.74M
--7.04M
-76.72%5.28M
--8.54M
-accounts payable
89.08%8.97M
89.08%8.97M
-48.40%3.63M
11.75%5.9M
-28.69%6.09M
-71.97%4.74M
-71.97%4.74M
--7.04M
-76.72%5.28M
--8.54M
Current accrued expenses
24.15%6.07M
24.15%6.07M
-33.85%4.23M
-44.31%5.68M
-39.28%6.05M
-39.02%4.89M
-39.02%4.89M
--6.39M
--10.19M
--9.97M
Current debt and capital lease obligation
-44.72%136K
-44.72%136K
-24.58%181K
-3.85%225K
486.05%252K
310.00%246K
310.00%246K
--240K
236.44%234K
--43K
-Current capital lease obligation
-44.72%136K
-44.72%136K
-24.58%181K
-3.85%225K
486.05%252K
310.00%246K
310.00%246K
--240K
236.44%234K
--43K
Current deferred liabilities
-33.64%3.99M
-33.64%3.99M
--0
--0
-62.67%3.03M
-32.81%6.01M
-32.81%6.01M
--4.5M
-42.46%6.06M
--8.12M
Other current liabilities
-30.42%57.27M
-30.42%57.27M
134.70%44.36M
-11.10%20.93M
-28.85%23.52M
554.62%82.31M
554.62%82.31M
--18.9M
180.39%23.55M
--33.06M
Current liabilities
-19.76%85.79M
-19.76%85.79M
41.25%58.27M
-19.41%36.51M
-31.50%40.91M
114.28%106.92M
114.28%106.92M
--41.26M
8.75%45.31M
--59.73M
Non current liabilities
Long term debt and capital lease obligation
-67.33%66K
-67.33%66K
-68.05%85K
-68.60%103K
--137K
--202K
--202K
--266K
1,212.26%328K
----
-Long term capital lease obligation
-67.33%66K
-67.33%66K
-68.05%85K
-68.60%103K
--137K
--202K
--202K
--266K
1,212.26%328K
----
Non current deferred liabilities
----
----
----
----
----
--0
--0
--0
-93.01%222K
--444K
Derivative product liabilities
----
----
----
----
----
--0
--0
--18.81M
63.18%13.39M
--16.49M
Total non current liabilities
-67.33%66K
-67.33%66K
-99.55%85K
-99.26%103K
-99.19%137K
-97.71%202K
-97.71%202K
--19.07M
22.21%13.94M
--16.93M
Total liabilities
-19.85%85.85M
-19.85%85.85M
-3.27%58.36M
-38.20%36.62M
-46.45%41.05M
82.47%107.12M
82.47%107.12M
--60.33M
11.65%59.25M
--76.66M
Shareholders'equity
Share capital
6.20%14.28M
6.20%14.28M
23.37%14.11M
25.67%14.01M
25.69%13.97M
32.15%13.44M
32.15%13.44M
--11.44M
-98.31%11.15M
--11.11M
-common stock
6.20%14.28M
6.20%14.28M
23.37%14.11M
25.67%14.01M
25.69%13.97M
32.15%13.44M
32.15%13.44M
--11.44M
-98.31%11.15M
--11.11M
Retained earnings
-36.49%-762.39M
-36.49%-762.39M
-47.40%-687.47M
-36.85%-615.46M
-45.61%-598.1M
-76.22%-558.57M
-76.22%-558.57M
---466.39M
-112.82%-449.75M
---410.74M
Paid-in capital
9.91%1.43B
9.91%1.43B
68.41%1.4B
67.43%1.38B
68.16%1.36B
119.74%1.3B
119.74%1.3B
--829.4M
--821.61M
--807.01M
Gains losses not affecting retained earnings
7.30%4.79M
7.30%4.79M
4.93%4.64M
-2.15%4.33M
0.27%4.43M
1.02%4.47M
1.02%4.47M
--4.42M
-48.96%4.42M
--4.42M
Total stockholders'equity
-9.78%683.43M
-9.78%683.43M
92.17%728.07M
100.93%778.5M
88.77%777.36M
162.66%757.5M
162.66%757.5M
--378.86M
-15.57%387.44M
--411.8M
Total equity
-9.78%683.43M
-9.78%683.43M
92.17%728.07M
100.93%778.5M
88.77%777.36M
162.66%757.5M
162.66%757.5M
--378.86M
-15.57%387.44M
--411.8M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -23.73%636.24M-23.73%636.24M66.29%702.95M71.62%739.16M68.03%808.48M145.03%834.19M145.03%834.19M--422.73M3.35%430.71M--481.15M
-Cash and cash equivalents -36.51%490M-36.51%490M27.36%538.41M30.92%563.86M55.55%748.42M126.68%771.74M126.68%771.74M--422.73M3.35%430.71M--481.15M
-Short-term investments 134.18%146.24M134.18%146.24M--164.54M--175.3M--60.06M--62.45M--62.45M------------
Receivables 8.67%23.15M8.67%23.15M293.49%20.25M265.33%19.75M-60.97%1.61M1,032.64%21.31M1,032.64%21.31M--5.15M-13.77%5.41M--4.13M
-Taxes receivable -28.04%231K-28.04%231K-94.11%206K-89.43%346K15.54%171K-68.09%321K-68.09%321K--3.5M--3.27M--148K
-Other receivables 9.23%22.92M9.23%22.92M1,117.68%20.04M809.28%19.4M-63.81%1.44M2,298.17%20.98M2,298.17%20.98M--1.65M-65.96%2.13M--3.99M
Prepaid assets 89.26%14.99M89.26%14.99M-21.74%7.83M18.40%10.94M183.79%7.21M77.53%7.92M77.53%7.92M--10M--9.24M--2.54M
Restricted cash --1.32M--1.32M--1.31M----------0--0------------
Total current assets -21.74%675.7M-21.74%675.7M67.25%732.33M72.86%769.85M67.54%817.3M148.97%863.41M148.97%863.41M--437.87M5.28%445.35M--487.82M
Non current assets
Net PPE -15.60%568K-15.60%568K-21.41%569K-21.32%620K336.69%607K566.34%673K566.34%673K--724K547.41%788K--139K
-Gross PPE -15.60%568K-15.60%568K-21.41%569K-21.32%620K336.69%607K566.34%673K566.34%673K--724K--788K--139K
Goodwill and other intangible assets -23.78%407K-23.78%407K-25.97%439K-13.28%470K3.29%502K214.12%534K214.12%534K--593K-99.39%542K--486K
Investments and advances --92.61M--92.61M--53.09M--44.17M------0--0------------
Non current prepaid assets ----------------------0--0--0-92.08%8K--16K
Total non current assets 7,653.44%93.58M7,653.44%93.58M4,007.74%54.1M3,282.81%45.26M73.01%1.11M294.44%1.21M294.44%1.21M--1.32M-98.50%1.34M--641K
Total assets -11.03%769.28M-11.03%769.28M79.06%786.43M82.48%815.11M67.55%818.41M149.10%864.62M149.10%864.62M--439.19M-12.75%446.69M--488.46M
Liabilities
Current liabilities
Payables 89.08%8.97M89.08%8.97M-48.40%3.63M11.75%5.9M-28.69%6.09M-71.97%4.74M-71.97%4.74M--7.04M-76.72%5.28M--8.54M
-accounts payable 89.08%8.97M89.08%8.97M-48.40%3.63M11.75%5.9M-28.69%6.09M-71.97%4.74M-71.97%4.74M--7.04M-76.72%5.28M--8.54M
Current accrued expenses 24.15%6.07M24.15%6.07M-33.85%4.23M-44.31%5.68M-39.28%6.05M-39.02%4.89M-39.02%4.89M--6.39M--10.19M--9.97M
Current debt and capital lease obligation -44.72%136K-44.72%136K-24.58%181K-3.85%225K486.05%252K310.00%246K310.00%246K--240K236.44%234K--43K
-Current capital lease obligation -44.72%136K-44.72%136K-24.58%181K-3.85%225K486.05%252K310.00%246K310.00%246K--240K236.44%234K--43K
Current deferred liabilities -33.64%3.99M-33.64%3.99M--0--0-62.67%3.03M-32.81%6.01M-32.81%6.01M--4.5M-42.46%6.06M--8.12M
Other current liabilities -30.42%57.27M-30.42%57.27M134.70%44.36M-11.10%20.93M-28.85%23.52M554.62%82.31M554.62%82.31M--18.9M180.39%23.55M--33.06M
Current liabilities -19.76%85.79M-19.76%85.79M41.25%58.27M-19.41%36.51M-31.50%40.91M114.28%106.92M114.28%106.92M--41.26M8.75%45.31M--59.73M
Non current liabilities
Long term debt and capital lease obligation -67.33%66K-67.33%66K-68.05%85K-68.60%103K--137K--202K--202K--266K1,212.26%328K----
-Long term capital lease obligation -67.33%66K-67.33%66K-68.05%85K-68.60%103K--137K--202K--202K--266K1,212.26%328K----
Non current deferred liabilities ----------------------0--0--0-93.01%222K--444K
Derivative product liabilities ----------------------0--0--18.81M63.18%13.39M--16.49M
Total non current liabilities -67.33%66K-67.33%66K-99.55%85K-99.26%103K-99.19%137K-97.71%202K-97.71%202K--19.07M22.21%13.94M--16.93M
Total liabilities -19.85%85.85M-19.85%85.85M-3.27%58.36M-38.20%36.62M-46.45%41.05M82.47%107.12M82.47%107.12M--60.33M11.65%59.25M--76.66M
Shareholders'equity
Share capital 6.20%14.28M6.20%14.28M23.37%14.11M25.67%14.01M25.69%13.97M32.15%13.44M32.15%13.44M--11.44M-98.31%11.15M--11.11M
-common stock 6.20%14.28M6.20%14.28M23.37%14.11M25.67%14.01M25.69%13.97M32.15%13.44M32.15%13.44M--11.44M-98.31%11.15M--11.11M
Retained earnings -36.49%-762.39M-36.49%-762.39M-47.40%-687.47M-36.85%-615.46M-45.61%-598.1M-76.22%-558.57M-76.22%-558.57M---466.39M-112.82%-449.75M---410.74M
Paid-in capital 9.91%1.43B9.91%1.43B68.41%1.4B67.43%1.38B68.16%1.36B119.74%1.3B119.74%1.3B--829.4M--821.61M--807.01M
Gains losses not affecting retained earnings 7.30%4.79M7.30%4.79M4.93%4.64M-2.15%4.33M0.27%4.43M1.02%4.47M1.02%4.47M--4.42M-48.96%4.42M--4.42M
Total stockholders'equity -9.78%683.43M-9.78%683.43M92.17%728.07M100.93%778.5M88.77%777.36M162.66%757.5M162.66%757.5M--378.86M-15.57%387.44M--411.8M
Total equity -9.78%683.43M-9.78%683.43M92.17%728.07M100.93%778.5M88.77%777.36M162.66%757.5M162.66%757.5M--378.86M-15.57%387.44M--411.8M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More